Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Amur Minerals ( (GB:CRTX) ) has provided an announcement.
CRISM Therapeutics Corporation announced the successful completion of a Retail Offer and an Additional Placing, raising a total of £874,021. The funds will support the development of ChemoSeed, including GMP manufacturing and clinical trials, positioning the company to advance its innovative cancer treatment technology.
More about Amur Minerals
CRISM Therapeutics Corporation is a company that has developed an innovative drug delivery technology aimed at improving the clinical performance of cancer treatments for solid tumors. Their lead product, ChemoSeed, is designed to deliver chemotherapy drugs directly into tumors or resection margins, enhancing treatment efficacy by bypassing barriers such as the blood-brain barrier in cases like high-grade glioma.
Average Trading Volume: 85,459
Technical Sentiment Signal: Sell
Current Market Cap: £1M
See more data about CRTX stock on TipRanks’ Stock Analysis page.